Neurochemical Research

, Volume 4, Issue 1, pp 1–14 | Cite as

What if multiple sclerosis isn't an immunological or a viral disease? the case for a circulating toxin

  • Frederick Wolfgram
Overview

Abstract

The literature contains studies on many causes of demyelination: Vascular occlusion —exogenous toxins—allergic reactions—and virus diseases. There remains, however, a small group of conditions which seems to have been ignored almost completely in discussions of cerebral demyelination. These consist of brain damage apparently resulting from some toxin liberated within the human body and not obtained from the outside.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baker, A. B. 1950. Demyelination resulting from endogenous toxins. Assoc. Res. Nerv. Ment. Dis. 28:59–74.Google Scholar
  2. 2.
    Dawson, J. W. 1916. The histology of disseminated sclerosis. Edinburgh Med. J. 17:377–410.Google Scholar
  3. 3.
    Hassin, G. B. 1922. Studies in the pathogenesis of multiple sclerosis. Arch. Neurol. Psychiatr. 7:589–607.Google Scholar
  4. 4.
    Globus, J. H., andStrauss, I. 1928. Progressive degenerative subcortical encephalopathy. Arch. Neurol. Psychiatr. 20:1190–1228.Google Scholar
  5. 5.
    Meyer, A., andTennent, T. 1936. Familial Schilder's disease. Brain 59:100–112.Google Scholar
  6. 6.
    Peters, G. 1968. Multiple sclerosis. Pages 821–843,in Minckler, J. (ed.), Pathology of the Nervous System, Vol. 1, McGraw-Hill, New York.Google Scholar
  7. 7.
    Lumsden, C. E. 1970. The neuropathology of multiple sclerosis. Pages 217–309,in Vinken, P., and Bruyn, G. W. (eds.), Handbook of Clinical Neurology, Vol. 9, North Holland Publ., Amsterdam.Google Scholar
  8. 8.
    Brownell, B., andHughes, J. T. 1962. The distribution of plaques in the cerebrum in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 25:315–320.Google Scholar
  9. 9.
    Hopf, H. C. 1965. Leitgeschwindigkeit motorischer nerven bei der multiplen sklerose und unter dem einfluss hoher cortisonmedikation. Dtsch. Z. Nervenheilkd. 187:522–526.Google Scholar
  10. 10.
    Hassin, G. B. 1921. Pathological studies in the pathogenesis of multiple sclerosis. Assoc. Res. Nerv. Ment. Dis. 2:144–156.Google Scholar
  11. 11.
    Hasson, J., Terry, R. D., andZimmerman, H. M. 1958. Peripheral neuropathology in multiple sclerosis. Neurology 8:503–510.Google Scholar
  12. 12.
    Margulis, M. S. 1933. Uber die pathologische anatomie und pathogenese der multiplen sklerose. Dtsch. Z. Nervenheilkd. 131:125–143.Google Scholar
  13. 13.
    Schob, F. 1907. Ein beitrag zur pathologischen anatomie der multiplen skelerose. Monatsschr. Psychiatr. Neurol. 22:62–87.Google Scholar
  14. 14.
    Strahuber, A. 1903. Ueber degenerations-und proliferations vorgange bei multipler sklerose des nervensystems, nebst bemerkungen zur aetiologie und pathogenese der erkrankung. Beitr. Pathol. Anat. 33:409–480.Google Scholar
  15. 15.
    Pollock, M., Calder, C., andAllpress, S. 1977. Peripheral nerve abnormality in multiple sclerosis. Ann. Neurol. 2:41–48.Google Scholar
  16. 16.
    Andrews, J. M. 1972. The ultrastructural neuropathology of multiple sclerosis. Pages 23–49,in Wolfgram, F., Ellison, G. W., Stevens, J. G., and Andrews, J. M. (eds.), Multiple Sclerosis: Immunology, Virology and Ultrastructure. UCLA Forum in Medical Sciences No. 16, Academic Press, New York.Google Scholar
  17. 17.
    Lampert, P. W. 1965. Demyelination and remyelination in experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 24:371–385.Google Scholar
  18. 18.
    Meyer, A. 1928. Experimentalle erfahrungen uber die kohlenoxydvergiftung des zentralnervensystems. Ztschr. Ges. Neurol. Psychiatr. 112:187–212.Google Scholar
  19. 19.
    Putnam, T. J., McKenna, J., andMorrison, L. R. 1931. Studies in multiple sclerosis. 1. The histogenesis of experimental sclerotic plaques and their relation to multiple sclerosis. JAMA 97:1591–1596.Google Scholar
  20. 20.
    Yant, W. P., Chornyak, J., Schrenck, H. H. Patty, F. A., andSayers, R. R. 1934. Studies in asphyxia. U.S. Treasury Dept., Public Health Bull. 211.Google Scholar
  21. 21.
    Ferraro, A. 1933. Experimental toxic encephalomyelopathy. Psychiatr. Q. 7:267–283.Google Scholar
  22. 22.
    Hurst, E. W. 1940. Experimental demyelination of the central nervous system. 1. The encephalopathy produced by potassium cyanide. Aust. J. Exp. Biol. Med. Sci. 18:201–223.Google Scholar
  23. 23.
    Hurst, E. W. 1942. Experimental demyelination of the central nervous system. 3. Poisoning with potassium cyanide, sodium azide, hydroxylamine, narcotics, carbon monoxide, etc. with some consideration of bilateral necrosis occurring in the basal nuclei. Aust. J. Exp. Biol. Med. Sci. 20:297–312.Google Scholar
  24. 24.
    Hurst, E. W. 1944. A review of some recent observations on demyelination. Brain 67:103–124.Google Scholar
  25. 25.
    Putnam, J. J. 1883. Lead poisoning simulating other diseases. J. Nerv. Ment. Dis. 10:466–469.Google Scholar
  26. 26.
    Verhaart, W. J. C. 1941. Lead encephalopathy simulating diffuse sclerosis in a Chinese infant. Am. J. Dis. Child. 61:1246–1250.Google Scholar
  27. 27.
    Sauer, R. M., Zook, B. C., andGarner, F. M. 1970. Demyelinating encephalomyelopathy associated with lead poisoning in nonhuman primates. Science 169:1091–1093.Google Scholar
  28. 28.
    Smith, M. E. 1973. Studies on the mechanism of demyelination: Triethyl tin-induced demyelination. J. Neurochem. 21:357–372.Google Scholar
  29. 29.
    Baker, A. B., andTichy, F. Y. 1953. The effect of the organic solvents and industrial poisonings on the central nervous system. Assoc. Res. Nerv. Ment. Dis. 32:475–505.Google Scholar
  30. 30.
    Korenke, H. D., andPribilla, O. 1969. Suicid durch einmalige inhalation von tetrachlorkohlenstoff (CCl4) mit leukoencephalopathie. Arch. Toxikol. 25:109–126.Google Scholar
  31. 31.
    Weil, A. 1930. The effect of hemolytic toxins on nervous tissue. Arch. Pathol. 9:828–842.Google Scholar
  32. 32.
    Gonsette, R., Andre-Balisaux, G., andDelmotte, P. 1966. Permeability of the cerebral vessels. VI. Experimental demyelination provoked by substances acting on the blood-brain barrier. Acta Neurol. Belg. 66:247–262.Google Scholar
  33. 33.
    Davis, L., Haven, H., Givens, J. H., andEmmett, J. 1931. Effects of spinal anesthetics on the spinal cord and its membranes. JAMA 97:1781–1785.Google Scholar
  34. 34.
    Friedman, E. D. 1953. Neurologic sequelae of spinal anesthesia. N. Y. State J. Med. 53:1864–1866.Google Scholar
  35. 35.
    Poser, C. M. 1973. Demyelination in the central nervous system in chronic alcoholism: Central pontine myelinolysis and Marchiafava-Bignami's disease. Ann. N.Y. Acad. Sci. 215:373–381.Google Scholar
  36. 36.
    Marchiafava, E., andBignami, A. 1903. Sopra un'alterazione del corpo calloso osservata in soggetti alcoclisti. Riv. Patol. Nerv. Ment. 8:544–549.Google Scholar
  37. 37.
    Ironside, R., Bosanquet, F. D., andMcMenemey, W. H. 1961. Central demyelination of the corpus collosum (Marchiafava-Bignami disease). Brain 84:212–230.Google Scholar
  38. 38.
    Lynch, M. J. G. 1960. Brain lesions in chronic alcoholism. Arch. Pathol. 69:342–353.Google Scholar
  39. 39.
    Adams, R. D., Victor, M., andMancall, E. L. 1959. Central pontine myelinolysis. Arch Neurol. Psychiatr. 81:154–172.Google Scholar
  40. 40.
    Klavins, J. V. 1963. Central pontine myelinolysis. J. Neuropathol. Exp. Neurol. 22:302–317.Google Scholar
  41. 41.
    Sherins, R. J., andVerity, M. A. 1968. Central pontine myelinolysis associated with acute haemorrhagic pancreatitis. J. Neurol. Neurosurg. Psychiatr. 31:583–588.Google Scholar
  42. 42.
    Chason, J. L., Landers, J. W., andGonzalez, J. E. 1964. Central myelinolysis. J. Neurol. Neurosurg. Psychiatr. 27:317–325.Google Scholar
  43. 43.
    Waechter, R. V., andHoldorff, B. 1973. Akute zentrale pontine myelinolyse mit multifokaler ausbreitung. Z. Neurol. 204:193–208.Google Scholar
  44. 44.
    Balo, J. 1928. Encephalitis periaxialis concentrica. Arch. Neurol. Psychiatr. 19:242–264.Google Scholar
  45. 45.
    Hallervorden, J., andSpatz, H. 1933. Uber die konzentrische sklerose und die physikalischchemischen faktoren bei der ausbreitung von entmarkungsprozessen. Arch. Psychiatr. 98:641–701.Google Scholar
  46. 46.
    Davison, C., andKeschner, M. 1933. Myelitic and myelopathic lesions (A clinicopathologic study). Arch. Neurol. Psychiatr. 29:600–614.Google Scholar
  47. 47.
    Alvord, E. C., Stevenson, L. D., Vogel, F. S., andEngle, R. L. 1950. Neuropathological findings in phenylpyruvic oligophrenia (phenylketonuia). J. Neuropath. Exp. Neurol. 9:298–310.Google Scholar
  48. 48.
    Forssman, H., Kristensson, K., Sourander, P., andSvennerholm, L. 1967. Histological and chemical studies of a case of phenylketonuria with long survival. J. Ment. Def. Res. 11:194–206.Google Scholar
  49. 49.
    Malamud, N. 1966. Neuropathology of phenylketonuria. J. Neuropathol. Exp. Neurol. 25:254–268.Google Scholar
  50. 50.
    Gatfield, P. D., Taller, E., Hinton, G. G., Wallace, A. C., Abdelnour, G. M., andHaust, M. D. 1968. Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. Can. Med. Assoc. J. 99:1215–1233.Google Scholar
  51. 51.
    Globus, J. H., andBender, M. B. 1936. Disseminated toxic degenerative encephalopathy (disseminated sclerosing demyelination) secondary to extensive and severe burns. J. Nerv. Ment. Dis. 83:518–529.Google Scholar
  52. 52.
    Solcher, H. 1971. Striare initiale entmarkungsherde nach verbrennung mit langerer uberlebungszeit. Acta Neuropathol. (Berlin) 19:75–78.Google Scholar
  53. 53.
    Knutson, J., andBaker, A. B. 1945. The central nervous system in uremia. Arch. Neurol. Psychiatr. 54:130–140.Google Scholar
  54. 54.
    Tichy, F. Y. 1950. Uremia encephalitis. J. Neuropathol. Exp. Neurol. 9:344–346.Google Scholar
  55. 55.
    Olsen, S. 1961. The brain in uremia. Acta Psychiatr. Neurol. Scand. 36(Suppl. 156):1–126.Google Scholar
  56. 56.
    Tyler, H. R. 1968. Neurologic disorders in renal failure. Am. J. Med. 44:734–748.Google Scholar
  57. 57.
    Giovannetti, S., andBarsotti, G. 1975. Uremic intoxication. Nephron 14:123–133.Google Scholar
  58. 58.
    Cohen, B. D. 1969. Guanidine retention and the urea cycle. Page 45,in 4th Int. Cong. Nephrology, Stockholm, June 22–27, Vol. 2, Karger, Basel.Google Scholar
  59. 59.
    Merrill, J. P., and Hampers, C. L. 1970. Uremia. N. Engl. J. Med. 282:953–961.Google Scholar
  60. 60.
    Adams, R. D., andFoley, J. M. 1953. The neurological disorder associated with liver disease. Assoc. Res. Nerv. Ment. Dis. 32:198–237.Google Scholar
  61. 61.
    Brown, I. A. 1957. Liver Brain Relationships, pp. 1–198, Charles C. Thomas, Springfield, Illinois.Google Scholar
  62. 62.
    Zieve, L., Mendelson, D. F., andGoepfert, M. 1960. Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy. Ann. Intern. Med. 53:53–63.Google Scholar
  63. 63.
    Bechar, M., Freud, M., Kott, E., Kott, I., Kravvic H., Stern, J., Sandbank, U., andBornstein, B. 1970. Hepatic cirrhosis with post-shunt myelopathy. J. Neurol. Sci. 11:101–107.Google Scholar
  64. 64.
    Baltzan, M. A., Olszewski, J., andZervas, N. 1957. Chronic portohepatic encephalopathy. J. Neuropathol. Exp. Neurol. 16:410–421.Google Scholar
  65. 65.
    Liversedge, L. A., andRawson, M. D. 1966. Myelopathy in hepatic disease and portosystemic venous anastomosis. Lancet 1:277–279.Google Scholar
  66. 66.
    Marquardt, P., andWerringloer, H. W. J. 1965. Toxicity of wine. Food Cosmet. Toxicol. 3:803–810.Google Scholar
  67. 67.
    Balo, J., andKopassy, B. 1932. The encephalitis of dogs with Eck fistula fed on meat. Arch. Pathol. 13:80–87.Google Scholar
  68. 68.
    Riddell, A. G., Kopple, P. N., andMcDermott, W. V., Jr 1954. The etiology of meat intoxication in the Eck fistula dog. Surgery 36:675–684.Google Scholar
  69. 69.
    Alter, M., Leibowitz, U., andSpeer, J.. 1966. Risk of multiple sclerosis related to age at immigration to Israel. Arch. Neurol. 15:234–237.Google Scholar
  70. 70.
    Alter, M., andOkihiro, M. 1971. When is multiple sclerosis acquired? Neurology 21:1030–1036.Google Scholar
  71. 71.
    Ikuta, F., andZimmerman, H. M.. 1976. Distribution of plaques in 70 autopsy cases of multiple sclerosis in the United States Neurology 26 (pt. 2):26–28.Google Scholar
  72. 72.
    Monseu, G., andFlament-Durand, J. 1971 Pathogenesis of central pontine myelinolysis. A clinical and pathological description of three cases. Pathol. Eur. 6:75–94.Google Scholar
  73. 73.
    Aleu, F. P., andTerry, R. D. 1963. Central pontine myelinolysis. A report of two cases. Arch. Pathol. 76:140–146.Google Scholar
  74. 74.
    Burkitt, D. P. 1971. The aetiology of appendicitis. Br. J. Surg. 58:695–699.Google Scholar
  75. 75.
    Burkitt, D. P. 1971. Epidemiology of cancer of the colon and rectum. Cancer 28:3–13.Google Scholar
  76. 76.
    Putnam, T. J. 1938. The centenary of multiple sclerosis. Arch. Neurol. Psychiatr. 40:806–813.Google Scholar
  77. 77.
    Firth, D. 1948. The Case of Auguste D'Este. University Press, Cambridge, England.Google Scholar
  78. 78.
    New York Neurological Society, 1902. Multiple Sclerosis. J. Nerv. Ment. Dis. 29:288–290.Google Scholar
  79. 79.
    Maretschek, M., Schaltenbrand, G., andSeibert, P. 1954. Statische untersuchungen uber die multiple skelerose an hand von 947 sektionsprotokollen. Dtsch. Z. Nervenheilkd. 172:287–308.Google Scholar
  80. 80.
    Poskanzer, D., Walker, A. M., Yonkondy, J., andSheridan, J. L. 1976. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 26 (pt. 2):14–17.Google Scholar
  81. 81.
    Leibowitz, U. 1971. Multiple sclerosis: Progress in epidemiologic and experimental research. J. Neurol. Sci. 12:307–318.Google Scholar
  82. 82.
    Dean, G. 1967. Annual incidence, prevalence and mortality of multiple sclerosis in white South-African born and in white immigrants to South Africa. Br. Med. J. 2:724–730.Google Scholar
  83. 83.
    Foster, R. M., andHarries, J. R. 1970. Multiple sclerosis in the African. Br. Med. J. 3:628.Google Scholar
  84. 84.
    Oh, S. J., andCalhoun, C. L. 1969. Multiple sclerosis in the Negro. J. Natl. Med. Assoc. 61:388–392.Google Scholar
  85. 85.
    Kurtzke, J. F., Kurland, L. T., andGoldberg, I. D. 1971. Mortality and migration in multiple sclerosis. Neurology 21:1186–1197.Google Scholar
  86. 86.
    Burbank, F. 1971 Patterns in cancer mortality in the United States: 1950–1967. Natl. Cancer Inst. Monag No. 33, National Institutes of Health, Bethesda, Maryland.Google Scholar
  87. 87.
    United States Department of Health, Education and Welfare 1963. Public Health Services. Cardiovascular Disease: 1960, Data on national and state mortality experience. Washington, D.C., Govt. Printing Office, PHS Publication No. 1083.Google Scholar
  88. 88.
    Strøm, A., andJensen, R.A. 1951. Mortality from circulatory disease in Norway 1940–1945. Lancet 1:126–129.Google Scholar
  89. 89.
    Swank, R. L. 1950. Multiple sclerosis: A correlation of its incidence with dietary fat. Am. J. Med. Sci. 220:421–430.Google Scholar

Copyright information

© Plenum Publishing Corporation 1979

Authors and Affiliations

  • Frederick Wolfgram
    • 1
  1. 1.Department of Neurology, Reed Neurological Research CenterUCLA School of MedicineLos Angeles

Personalised recommendations